CDCl3, ppm): 19.3 (d, J = 22 Hz, CH3CHF), 21.3 (CH3CO),
41.4 (CH2NCH2), 46.2 (CH2NCH2), 53.3 (CH2NCH2), 53.7
(CH2NCH2), 63.5 (d, J = 20 Hz, CH2CHF), 88.9 (d, J = 167 Hz,
20 Hz, CH2CF), 97.2 (d,1JC-F = 172 Hz, CF), 124.3 (CHarom), 128.6
(CHarom), 140.3 (Carom), 150.1 (Carom), 166.1 (CO), 169.3 (CO). 19
F
1
{ H} NMR (282 MHz, CDCl3, ppm): -154.2. HRMS (ESI): Calc
CH3CHF), 168.9 (CO). 19F { H} NMR (282 MHz, CDCl3, ppm):
for [M - HF]+ (C17H22N4O4) : 346.16411, found 346.1625.
1
-174.3. MS (EI, 70 ev): m/z (relative intensity%) 189 [M +
H+]+ (20). HRMS (ESI): Calc for C9H16N2O: 168.12626, found
168.1263.
Compound 6b: 1-(4-(7-(4-acetyl-piperazin-1-yl)-4-fluoro-4-
methyl-heptyl)-piperazin-1-yl)ethanone. Optimized procedure
(10 min reaction time) was followed, starting from 182 mg of
4g (1 mmol). Purification by flash column chromatography
(89.5/10/0.5: dichloromethane/methanol/NH3 aq) afforded
126 mg of the title compound as a colourless oil (66%). 1H
Compound 5b: 1-(4-(2-fluoro-2-methyl-propyl)-piperazin-1-yl)-
ethanone. Optimized procedure (10 min reaction time)
was followed, starting from 182 mg of 4b (1 mmol).
Purification by flash column chromatography (98.5/1/0.5:
dichloromethane/methanol/NH3 aq) afforded 171 mg of the
3
NMR (300 MHz, CDCl3, ppm): 1.28 (3H, d, JHF =21.7 Hz,
CH3CF), 1.59 (8H, m, NCH2CH2CH2), 2.05 (6H, s, CH3CO),
2.32 (12H, m, CH2NCH2); 3,43 (4H, t, J=4.8 Hz, CH2NCH2),
3,58 (4H, t, J=4.8 Hz, CH2NCH2). 13C NMR (75 MHz,
CDCl3, ppm): 21.4 (d,3JC-F =5 Hz, NCH2CH2CH2CF), 21.7
(CH3CO), 24.5 (d,2JC-F = 25 Hz, CH3CF), 37.5 (d,2JC-F = 23 Hz,
NCH2CH2CH2CF), 41.7 (CH2NCH2), 46.6 (CH2NCH2), 53.1
(CH2NCH2), 53.7 (CH2NCH2), 58.8 (NCH2CH2CH2CF), 97.3
1
title compound as a colourless oil (85%). H NMR (300 MHz,
3
CDCl3, ppm): 1.34 (6H, d, JHF =21.4 Hz, CH3CFCH3), 2.05
(3H, s, CH3CO), 2.42 (2H, d, 3JHF =22.8 Hz, CH2CF), 2.52 (2H,
2t, J=5.1 Hz, CH2NCH2), 2.56 (2H, 2t, J=5.1 Hz, CH2NCH2),
3.45 (2H, t, J=5.1 Hz, CH2NCH2), 3.61 (2H, t, J=5.1 Hz,
CH2NCH2). 13C NMR (75 MHz, CDCl3, ppm): 21.7 (s, CH3,
CH3CO), 25.5 (d,2JC-F = 24 Hz, CH3CFCH3), 41.9 (CH2NCH2),
1
(d,1JC-F = 166 Hz, NCH2CH2CH2CF), 169.3 (CO). 19F { H}
4
46.8 (CH2NCH2), 54.6 (d, JC-F = 3.1 Hz, CH2NCH2), 54.8 (d,
NMR (282 MHz, CDCl3, ppm): -145.5. HRMS (ESI): Calc for
2
4JC-F = 3.1 Hz, CH2NCH2), 66.5 (d, JC-F = 21 Hz, CH2CF),
C20H38N4O2F: 385.29788, found 385.2975.
1
96.9 (d,1JC-F = 240 Hz, CH3CFCH3), 169.3 (CO). 19F { H} NMR
(282 MHz, CDCl3, ppm): -139.6. MS (GCT, CI+): m/z (relative
intensity%) 202(50), 182(60), 141(100). HRMS (ESI): Calc for
C10H19N2OF: 202.14814, found 202.1461.
Acknowledgements
We thank the region Poitou-Charentes (grant to F.L.), the CNRS
and the University of Poitiers for financial support.
Compound 5c: 1-(4-(2-fluoro-2-phenyl-propyl)-piperazin-1-yl)-
ethanone. Optimized procedure (10 min reaction time)
was followed, starting from 244 mg of 4c (1 mmol).
Purification by flash column chromatography (96.5/3/0.5:
dichloromethane/methanol/NH3 aq) afforded 108 mg of the
Notes and references
1 (a) D. O’Hagan, Chem. Soc. Rev., 2008, 308; B. E. Smart, J. Fluorine
Chem., 2001, 3; (b) B. E. Smart, in Chemistry of Organic Fluorine
Compounds II: A Critical Review, M. Hudlicky, A. E. Pavlath, Eds.,
ACS Monograph 187, American Chemical Society, Washington, DC,
1995, pp. 979–1010; (c) B. E. Smart, in Organofluorine Chemistry:
Principles and Commercial Applications, R. E. Banks, B. E. Smart,
J. C. Tatlow, Eds., Plenum Publishing Corporation, New York, 1994,
pp. 57–88.
1
title compound as a colourless oil (41%). H NMR (300 MHz,
3
CDCl3, ppm): 1.72 (3H, d, JHF =22.7 Hz, CH3CFPh), 2.05
(3H, s, CH3CO), 2.57 (6H, m, CH2NCH2 and CH2CFPh), 3.37
(2H, m, CH2NCH2), 3.55 (2H, m, CH2NCH2), 7.32 (5H, m,
Harom). 13C NMR (75 MHz, CDCl3, ppm): 19.8 (CH3CO), 23.0
(d,2JC-F = 24 Hz, CH3CFPh), 40.0 (CH2NCH2), 44.8 (CH2NCH2),
2 J-P. Be´gue´ and D. Bonnet-Delpon, in Chimie Bioorganique et me´dicinale
du fluor, CNRS Edition, Paris, 2005.
2
52.6 (CH2NCH2), 52.8 (CH2NCH2), 65.7 (d, JC-F = 23 Hz,
3 (a) S. Purser, P. M. Moore, S. Swallow and V. Gouverneur, Chem. Soc.
Rev., 2008, 37, 320; (b) J-P. Be´gue´ and D. Bonnet-Delpon, J. Fluorine
Chem., 2006, 127, 992; (c) K. L. Kirk, J. Fluorine Chem., 2006, 127,
1013.
4 M. Morgenthaler, E. Schweiser, F. Hoffman-Roder, F. Benini, R. E.
Martin, G. Jaeschke, B. Wagner, H. Fisher, S. Bendels, D. Zimmerili,
J. Schneider, F. Hiedrich, M. Kansy and K. Muller, ChemMedChem.,
2007, 2, 1100.
CH2, CH2CFPh), 96.8 (d,1JC-F = 173 Hz, CH2CFPh), 122.8
(CHarom), 122.9 (CHarom), 125.9 (CHarom), 126.5 (CHarom), 142.0
1
(d,2JC-F = 22 Hz, Carom), 167.3 (CO). 19F { H} NMR (282 MHz,
CDCl3, ppm): -148.5. MS (GCT, CI+): m/z (relative intensity%)
244 (25), 172(40), 141(100). HRMS (ESI): Calc for C15H21N2OF:
264.16379, found 264.1656.
5 M. Rowley, D. J. Hallett, S. Goodacre, C. Moyes, J. Crawforth, T. J.
Sparey, S. Patel, R. Marwood, S. Thomas, L. Hitzel, D. O’Connor, N.
Szeto, J. L. Castro, P. H. Huston and A. M. Macloed, J. Med. Chem.,
2001, 44, 1603.
Compound 5f: N-(3-(4-acetylpiperazin-1-yl)-2-fluoro-2-methyl-
propyl)-4-nitrobenzamide. Optimized procedure (10 min re-
action time) was followed, starting from 374 mg of 4f
(1 mmol). Purification by flash column chromatography (98/2:
dichloromethane/methanol) afforded 226 mg of the title com-
6 W. H. Hagmann, J. Med. Chem., 2008, 51, 4359.
7 (a) J. M. Percy, Science of Synthesis, 2006, 34(10), 379; (b) S. Fustero,
J. F. Sanz-Cervera, J. L. Acena and M. Sanchez-Rosello, Synlett, 2009,
(4), 525.
pound as
a
colourless oil (62%). 1H NMR (300 MHz,
8 (a) G. M. Alvernhe, S. Lacombe and A. J. Laurent, Tetrahedron Lett.,
1980, 21, 289; (b) G. M. Alvernhe, C. M. Ennakoua, S. M. Lacombe
and A. J. Laurent, J. Org. Chem., 1981, 46, 4938; (c) R. H. Fan, Y. G.
Zhou, W. X. Zhang, X. L. Hou and L. X. Dai, J. Org. Chem., 2004, 69,
335.
9 (a) L. Somekh and A. Shanzer, J. Am. Chem. Soc., 1982, 104, 5836;
(b) J-W. Chern, J-Y. Chang, C. O. Usifoh and A. Gutsait, Tetrahedron
Lett., 1998, 39, 8483; (c) D. J. Hallett, U. Gerhard, S. C. Goodacre, L.
Hitzel, T. J. Sparey, S. Thomas and M. Rowley, J. Org. Chem., 2000, 65,
4984; (d) G. L. Grunewald, T. M. Caldwell, Q. Li and K. R. Criscione,
J. Med. Chem., 2001, 44, 2849; (e) L. Somekh and A. Shanzer, J. Org.
3
CDCl3, ppm): 1.34 (3H, d, JHF =21.8 Hz, CH3CF), 2.01 (3H, s,
CH3CO); 2,60 (6H, m, CH2NCH2 and CH2CF), 3.39 (2H, t, J
=4.7 Hz, CHaHbNCHaHb), 3.70 (4H, m, CHaHbNCHaHb and
CH2CF), 7.63 (1H, t, J =4.9 Hz; NH), 7.96 (2H, d, J =8.6 Hz;
H
arom), 8.23 (2H, d, J=8.6 Hz; Harom). 13C NMR (75 MHz,
CDCl3, ppm): 21.7 (CH3CO), 22.4 (d,2JC-F = 23 Hz, CH3CF),
2
41.9 (CH2NCH2), 46.7 (CH2NCH2), 47.3 (d, JC-F = 22 Hz,
2
CH2CF), 54.8 (CH2NCH2), 55.2 (CH2NCH2), 64.7 (d, JC-F
=
4796 | Org. Biomol. Chem., 2009, 7, 4789–4797
This journal is
The Royal Society of Chemistry 2009
©